Related Experiment Video
Updated: Nov 30, 2025
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
Nanoparticle cancer vaccines: Design considerations and recent advances
Jingjing Liu1, Lei Miao2, Jiying Sui3
1The School of Pharmaceutical Sciences, Shandong University, Ji'nan 250012, China.
Abstract:
Vaccines therapeutics manipulate host's immune system and have broad potential for cancer prevention and treatment. However, due to poor immunogenicity and limited safety, fewer cancer vaccines have been successful in clinical trials. Over the past decades, nanotechnology has been exploited to deliver cancer vaccines, eliciting long-lasting and effective immune responses. Compared to traditional vaccines, cancer vaccines delivered by nanomaterials can be tuned towards desired immune profiles by (1) optimizing the physicochemical properties of the nanomaterial carriers, (2) modifying the nanomaterials with targeting molecules, or (3) co-encapsulating with immunostimulators. In order to develop vaccines with desired immunogenicity, a thorough understanding of parameters that affect immune responses is required. Herein, we discussed the effects of physicochemical properties on antigen presentation and immune response, including but not limited to size, particle rigidity, intrinsic immunogenicity. Furthermore, we provided a detailed overview of recent preclinical and clinical advances in nanotechnology for cancer vaccines, and considerations for future directions in advancing the vaccine platform to widespread anti-cancer applications.
Insights
Nanotechnology enhances cancer vaccines by improving immune responses and safety. Optimizing nanomaterial properties and co-delivery strategies are key for effective cancer prevention and treatment.
Area of Science:
- Immunology
- Nanotechnology
- Oncology
Background:
- Cancer vaccines aim to harness the immune system for prevention and treatment.
- Traditional cancer vaccines face challenges with poor immunogenicity and limited safety.
- Nanotechnology offers a promising platform to overcome these limitations.
Purpose of the Study:
- To review the impact of nanotechnology on cancer vaccine development.
- To discuss how nanomaterial properties influence immune responses.
- To highlight recent advances and future directions in nanovaccines for cancer.
Main Methods:
- Review of preclinical and clinical studies on nanotechnology-based cancer vaccines.
- Analysis of physicochemical properties of nanomaterials (e.g., size, rigidity) and their effect on antigen presentation.
- Exploration of strategies like targeted modification and co-encapsulation of immunostimulators.
Main Results:
- Nanomaterial carriers can be engineered to elicit potent and long-lasting immune responses.
- Physicochemical properties of nanomaterials significantly affect antigen presentation and immunogenicity.
- Targeted modifications and co-delivery of adjuvants enhance vaccine efficacy.
Conclusions:
- Nanotechnology is crucial for developing next-generation cancer vaccines with improved immunogenicity and safety.
- Understanding nanomaterial-host interactions is essential for rational vaccine design.
- Further advancements in nanovaccine platforms hold significant potential for widespread clinical application against cancer.
More Related Videos
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy